Orencia (abatacept) — Clinical Medical Policy (coverage criteria)
Customize your policy alerts
Sign up for Anthem Policy CC-0078 alerts
Get alerted when Policy CC-0078 changes without checking for updates manually.
Monitor payer policy activity
Clinical medical policy governing prior authorization, step therapy, quantity limits, and coverage criteria for Orencia (abatacept) for Anthem members, including indications such as rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, GVHD prophylaxis, chronic GVHD, and immune checkpoint inhibitor–related toxicities.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.